Ledger.Open graph →
SEC Form D · filed April 22, 2021

Revelation Biosciences, Inc

Offering
$4.4M
Sold
$4.4M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
SAN DIEGO, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (17)

Jess F. Roper · San Diego, CADirectorJames M. Rolke · San Diego, CAExec · DirectorSven Borre Larsen · Oslo, Q8Exec · DirectorGrethe Moen · Oslo, Q8DirectorDavid Welch · Oakland, CAExec · DirectorChester S. Zygmont · Menlo Park, CAExecJan Schoolmeesters · Oslo, Q8DirectorCurt F. Labelle · San Diego, CADirectorMatt Blodgett · San Francisco, CADirectorChristopher Finlayson · Oslo, Q8DirectorGeorge F. Tidmarsh · San Diego, CADirectorJulian N. Fletcher · Grand Cayman, Cayman IslandsDirectorNavus Capital Management LP · Oakland, CADirectorJennifer F. Carver · San Diego, CADirectorRajan Lukose · Oakland, CADirectorChester S. Zygmont · Menlo Park, CAExecDoonaye Sookye · Morc St Andre, O4Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗